Washington: The US Food and Drug Administration (FDA) has approved a drug to treat moderate to severe binge eating disorder (BED) in adults - a first of its kind prescription drug specifically indicated for BED.

The new drug lisdexamfetamine dimesylate will be available under the brand name Vyvanse, the US-based The Obesity Society (TOS) said in a statement.